MIR4639

Across TCGA pan-cancer cohorts, MIR4639 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR4639 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR4639 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR4639 expression acts as an unfavorable survival marker, although some lineages such as LUSC and OV show a favorable association.

LUSC, OV, and READ are the cancer types where MIR4639 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.733	0.403	.001	41	view →
OV	DFS	Tertile	II,III,IV	0.581	0.492	.013	24	view →
READ	DFS	Tertile	IV	0.372	0.772	.004	18	view →
LUAD	OS	Quartile	II,III,IV	0.608	0.265	.003	15	view →
CHOL	OS	Tertile	II,III,IV	1.000	0.504	.024	13	view →
SKCM	DFS	Tertile	IV	0.943	0.154	.015	11	view →
BLCA	DFS	Tertile	All	0.396	0.270	.017	10	view →
GBM	OS	Tertile	All	0.149	0.443	<.001	9	view →
PCPG	OS	Quartile	All	0.780	0.981	.014	9	view →
PAAD	DFS	Quartile	II,III,IV	0.552	0.291	.018	8	view →
PRAD	OS	Tertile	All	0.981	1.000	.005	8	view →
BRCA	DFS	Tertile	III,IV	0.935	0.843	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR4639–LUSC (OS)

Open the LUSC breakdown →